Regeneron Pharmaceuticals Market Sentiment

SPY780.02+0.12%QQQ760.49+0.11%BTC/USD85,649.00−0.12%DIA514.85+0.06%GLD381.79−0.13%TLT77.30+0.03%

Regeneron Pharmaceuticals Inc

REGNNASDAQ

Trade with Public

$738.72

12.251.69%

Last update: Oct 6, 4:41 PM

$738.72

12.251.69%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Dividends Compare Options Stock Report

Regeneron Pharmaceuticals Market Sentiment - Benzinga

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

—

Avg Consensus PT

$810

+9.6%

Highest Price Target

$1030

+39.4%

Guggenheim

Lowest Price Target

$185

-75.0%

Benchmark

Short Interest

2.6%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 6, 2026	JP Morgan	Chris Schott—	+28.6%	$900 → $950	Maintained	Overweight
Oct 1, 2026	Jefferies	Akash Tewari—	+25.9%	$870 → $930	Maintained	Buy
Oct 1, 2026	Argus Research	Jasper Hellweg—	+15.1%	$850	Upgrade	Hold→Buy
Sep 29, 2026	RBC Capital	Brian Abrahams—	-0.2%	$737 → $737	Maintained	Sector Perform
Sep 10, 2026	HSBC	Rajesh Kumar—	+24.5%	$800 → $920	Maintained	Buy
Aug 17, 2026	Leerink Partners	David Risinger—	+11.5%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	+0.2%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+39.4%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-0.2%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	+2.6%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	+7.6%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	+1.5%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	+4.5%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+35.4%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+15.6%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-1.2%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-5.8%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	+4.1%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-75.0%	$185	Upgrade	Hold→Buy
Jul 6, 2026	HSBC	Rajesh Kumar—	+19.1%	$990 → $880	Maintained	Buy
Jul 6, 2026	Cantor Fitzgerald	Carter Gould—	+1.5%	$785 → $750	Maintained	Overweight
May 19, 2026	Canaccord Genuity	John Newman—	+18.4%	$1057 → $875	Maintained	Buy
May 18, 2026	BMO Capital	Evan David Seigerman—	-1.2%	$900 → $730	Maintained	Outperform
May 18, 2026	Truist Securities	Gregory Renza—	+5.3%	$796 → $778	Maintained	Buy
May 18, 2026	JP Morgan	Chris Schott—	+15.1%	$950 → $850	Maintained	Overweight